| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |